Product
exemestane
Aliases
Aromasin
Name
Exemestane
INN Name
exemestane
FDA Approved
Yes
2 clinical trials
14 organizations
3 indications
2 documents
Indication
Breast NeoplasmsIndication
Breast CancerIndication
Estrogen receptor-positive breast cancerClinical trial
A Randomized Phase 2 Non-inferiority Trial of (Z)-Endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment in Premenopausal Women With ER+/HER2- Breast CancerStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF EFFICACY AND SAFETY OF ENZALUTAMIDE IN COMBINATION WITH EXEMESTANE IN PATIENTS WITH ADVANCED BREAST CANCER THAT IS ESTROGEN OR PROGESTERONE RECEPTOR-POSITIVE AND HER2-NORMALStatus: Active (not recruiting), Estimated PCD: 2016-09-23
Organization
Upsher-Smith Laboratories, Inc.Organization
Aurobindo Pharma LimitedOrganization
Zydus Pharmaceuticals USA Inc.Document
DailyMed Label: AromasinOrganization
Pharmacia & Upjohn Company LLCDocument
DailyMed Label: ExemestaneOrganization
A-S Medication SolutionsOrganization
Greenstone LLCOrganization
Florida Pharmaceutical Products, LLCOrganization
Zydus Lifesciences LimitedOrganization
Cipla USA Inc.Organization
Hikma Pharmaceuticals USA Inc.Organization
Amneal Pharmaceuticals LLCOrganization
bryant ranch prepackOrganization
Breckenridge Pharmaceutical, Inc.Organization
Physicians Total Care, Inc.